Rosetta Capital (UK) Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
5
- Investments
-
70
- Portfolio
-
10
- Exits
-
55
Rosetta Capital (UK) General Information
Company Description
Founded in 2001, Rosetta Capital is a venture capital investment firm based in Haddenham, United Kingdom. The firm prefers to invest through direct secondary transactions in companies operating in the life science, healthcare, medical devices, and medical technology sectors. The firm prefers to invest in Europe, North America, and Asia.
Business Details
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- Rectory House
- Haddenham HP17 8DA
- England, United Kingdom
Rosetta Capital (UK) Investments (70)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Mission Therapeutics | 15-Oct-2025 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 2 | ||
| Mission Therapeutics | 11-Mar-2024 | Drug Discovery | Clinical Trials - Phase 2 | |||
| JenaValve Technology | 01-Mar-2023 | Therapeutic Devices | Generating Revenue | |||
| Carrick Therapeutics | 03-Mar-2022 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Carrick Therapeutics | 15-Mar-2021 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Inivata | 15-Mar-2021 | Diagnostic Equipment | Generating Revenue | |||
| Mereo Biopharma Group | 15-Mar-2021 | Drug Discovery | Generating Revenue | |||
| ReNeuron Group | 15-Mar-2021 | Drug Discovery | Bankruptcy: Admin/Reorg | |||
| Oxular | 01-Mar-2021 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 2 | ||
| Akamis Bio | 27-Jan-2021 | Secondary Transaction - Private | Drug Discovery | Clinical Trials - Phase 1 |
Rosetta Capital (UK) Exits (55)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Oxular | 02-Jan-2025 | Merger/Acquisition | |
| Forward Pharma | 01-Jan-2025 | ||
| Mereo Biopharma Group | 17-Jun-2024 | ||
| ReNeuron Group | 20-Mar-2024 | ||
| Promore Pharma | 29-Dec-2023 | ||
| Librestream | 01-Sep-2023 | ||
| FiberSense (Monitoring Equipment) | 01-Nov-2022 | ||
| Clanotech | 02-Jun-2022 | ||
| Promimic | 29-Apr-2022 | IPO | |
| Axelar (Drug Discovery) | 22-Oct-2021 | Out of Business |
Rosetta Capital (UK) Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
Rosetta Capital (UK) Investments by Industry, Year, and Region
Rosetta Capital (UK) Co-Investors (11)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| ARCH Venture Partners | 1 |
|
|
||
| IP Group |
|
|
|||
| Roche Venture Fund |
|
|
|||
| SR One |
|
|
|||
| Sofinnova Partners |
|
|
Rosetta Capital (UK) Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Clanotech | Solna, Sweden | 2005 |
Rosetta Capital (UK) FAQs
-
What is Rosetta Capital (UK)?
Founded in 2001, Rosetta Capital is a venture capital investment firm based in Haddenham, United Kingdom.
-
When was Rosetta Capital (UK) founded?
Rosetta Capital (UK) was founded in 2001.
-
Where is Rosetta Capital (UK) headquartered?
Rosetta Capital (UK) is headquartered in Haddenham, United Kingdom.
-
How many investments has Rosetta Capital (UK) made?
Rosetta Capital (UK) has made 70 investments.
-
What has Rosetta Capital (UK) invested in?
Rosetta Capital (UK) has made numerous investments in companies like Mission Therapeutics, JenaValve Technology, and Carrick Therapeutics within the Drug Discovery and Therapeutic Devices industries.
-
What has Rosetta Capital (UK) invested in recently?
Rosetta Capital (UK)'s latest investment was on 15-Oct-2025 in Mission Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process